CWC15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.001000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.689000E-01
Normal-vs-Stage2
6.887200E-01
Normal-vs-Stage3
7.799400E-01
Normal-vs-Stage4
3.956600E-01
Stage1-vs-Stage2
6.919400E-01
Stage1-vs-Stage3
6.395800E-01
Stage1-vs-Stage4
5.254000E-01
Stage2-vs-Stage3
3.886200E-01
Stage2-vs-Stage4
8.412400E-01
Stage3-vs-Stage4
4.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.443000E-01
Normal-vs-AfricanAmerican
4.250800E-01
Normal-vs-Asian
4.938400E-01
Caucasian-vs-AfricanAmerican
5.595800E-01
Caucasian-vs-Asian
3.994000E-01
AfricanAmerican-vs-Asian
9.649000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.480800E-01
Normal-vs-Female
6.407000E-01
Male-vs-Female
6.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.836180E-01
Normal-vs-Age(41-60Yrs)
2.997200E-01
Normal-vs-Age(61-80Yrs)
8.740200E-01
Normal-vs-Age(81-100Yrs)
5.173400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.384500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.047000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.199900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.132030E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.675400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.426000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.663000E-01
Normal-vs-Daily Drinker
7.305400E-01
Normal-vs-Weekly Drinker
8.925800E-01
Normal-vs-Occasional Drinker
6.098000E-01
Normal-vs-Social Drinker
4.999800E-01
Non Drinker-vs-Daily Drinker
7.336000E-01
Non Drinker-vs-Weekly Drinker
9.165200E-01
Non Drinker-vs-Occasional Drinker
6.913600E-01
Non Drinker-vs-Social Drinker
5.849400E-01
Daily Drinker-vs-Weekly Drinker
6.820800E-01
Daily Drinker-vs-Occasional Drinker
9.636000E-01
Daily Drinker-vs-Social Drinker
8.260000E-01
Weekly Drinker-vs-Occasional Drinker
6.009400E-01
Weekly Drinker-vs-Social Drinker
4.891600E-01
Occasional Drinker-vs-Social Drinker
8.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.470400E-01
Normal-vs-Grade 2
6.224000E-01
Normal-vs-Grade 3
6.021200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.833900E-02
Grade 1-vs-Grade 3
4.563700E-02
Grade 1-vs-Grade 4
3.470400E-01
Grade 2-vs-Grade 3
5.861800E-01
Grade 2-vs-Grade 4
6.224000E-01
Grade 3-vs-Grade 4
6.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.369000E-01
Normal-vs-NonDiabetic
5.706800E-01
Diabetic-vs-NonDiabetic
4.531700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.307700E-02
Normal-vs-NoPancreatitis
7.849000E-01
Pancreatitis-vs-NoPancreatitis
5.259700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.990800E-01
Normal-vs-N1
7.318200E-01
N0-vs-N1
4.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.693650E-01
Normal-vs-TP53-NonMutant
5.875400E-01
TP53-Mutant-vs-TP53-NonMutant
1.00749999998317E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
